MedTrace Logo

Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV

NCT06589167 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-09-19

No results posted yet for this study

Summary

1. investigate the Prevalence of combined hepatic steatosis in patients with chronic HBV.
2. to evaluate clinical characteristics of chronic HBV patients combined with metabolic syndrome and hepatic steatosis

Conditions

  • Metabolic Syndrome
  • Fatty Liver Disease

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hadeer Abd El-Sattar · Assiut University

  • Ghadaa Abdel rahman · Assiut University

  • Bahaa Osman Taha · Assiut University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-07
Primary Completion
2025-09-07
Completion
2025-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06589167 on ClinicalTrials.gov